<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">18181532</PMID>
        <DateCompleted>
            <Year>2008</Year>
            <Month>01</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-9932</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2007</Year>
                        <Month>Dec</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>AAPS PharmSciTech</Title>
                <ISOAbbreviation>AAPS PharmSciTech</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>E111</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1208/pt0804111</ELocationID>
            <Abstract>
                <AbstractText>The purpose of the present research was to investigate the mechanism for improved intercellular and intracellular drug delivery from ethosomes using visualization techniques and cell line study. Ethosomal formulations were prepared using lamivudine as model drug and characterized in vitro, ex vivo and in vivo. Transmission electron microscopy, scanning electron microscopy, and fluorescence microscopy were employed to determine the effect of ethosome on ultrastructure of skin. Cytotoxicity and cellular uptake of ethosome were determined using T-lymphoid cell line (MT-2). The optimized ethosomal formulation showed 25 times higher transdermal flux (68.4 +/- 3.5 microg/cm(2)/h) across the rat skin as compared with that of lamivudine solution (2.8 +/- 0.2 microg/cm(2)/h). Microscopic studies revealed that ethosomes influenced the ultrastructure of stratum corneum. Distinct regions with lamellar stacks derived from vesicles were observed in intercellular region of deeper skin layers. Results of cellular uptake study showed significantly higher intracellular uptake of ethosomes (85.7% +/- 4.5%) as compared with drug solution (24.9% +/- 1.9%). The results of the characterization studies indicate that lipid perturbation along with elasticity of ethosomes vesicles seems to be the main contributor for improved skin permeation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jain</LastName>
                    <ForeName>Subheet</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Patiala [Punjab] 147 002 India. subheetjain@rediffmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tiwary</LastName>
                    <ForeName>Ashok K</ForeName>
                    <Initials>AK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sapra</LastName>
                    <ForeName>Bharti</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jain</LastName>
                    <ForeName>Narendra K</ForeName>
                    <Initials>NK</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2007</Year>
                <Month>12</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>AAPS PharmSciTech</MedlineTA>
            <NlmUniqueID>100960111</NlmUniqueID>
            <ISSNLinking>1530-9932</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018894">Reverse Transcriptase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2T8Q726O95</RegistryNumber>
                <NameOfSubstance UI="D019259">Lamivudine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>3K9958V90M</RegistryNumber>
                <NameOfSubstance UI="D000431">Ethanol</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000279" MajorTopicYN="N">Administration, Cutaneous</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015194" MajorTopicYN="N">Diffusion Chambers, Culture</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004339" MajorTopicYN="N">Drug Compounding</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004355" MajorTopicYN="N">Drug Stability</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004548" MajorTopicYN="N">Elasticity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019259" MajorTopicYN="N">Lamivudine</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008855" MajorTopicYN="N">Microscopy, Electron, Scanning</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010539" MajorTopicYN="N">Permeability</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018894" MajorTopicYN="N">Reverse Transcriptase Inhibitors</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012869" MajorTopicYN="Y">Skin Absorption</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013678" MajorTopicYN="N">Technology, Pharmaceutical</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2008</Year>
                <Month>1</Month>
                <Day>10</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2008</Year>
                <Month>1</Month>
                <Day>25</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2008</Year>
                <Month>1</Month>
                <Day>10</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">18181532</ArticleId>
            <ArticleId IdType="doi">10.1208/pt0804111</ArticleId>
            <ArticleId IdType="pmc">PMC2750697</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Control Release. 2000 Apr 3;65(3):403-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10699298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2007 Apr;1770(4):681-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17276009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnopharmacol. 2001 Sep;77(1):113-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11483387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomaterials. 2001 Nov;22(22):3053-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11575480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Dev Ind Pharm. 2003 Oct;29(9):1013-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14606665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Control Release. 2004 Feb 10;94(2-3):365-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14744487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharm Dev Technol. 2004;9(1):63-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15000467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 1965 Aug;13(1):253-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5859040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Biochem. 1983;52:223-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6311077</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 1995 Aug;9(8):833-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7576316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Microsc. 1997 Aug;187(Pt 2):125-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9316270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Pharm. 1999 Apr 15;180(2):261-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10370196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs. 1999 Jul;58(1):101-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10439933</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Pharm. 2005 Jul 14;298(1):1-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15896932</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Control Release. 2005 Aug 18;106(1-2):99-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15935505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Drug Deliv. 2005 Jul;2(3):223-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16305424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomaterials. 2000 Sep;21(18):1879-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10919691</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
